MED Stock Recent News
MED LATEST HEADLINES
Medifast's (MED) first-quarter results reflect challenges related to a decline in active earning OPTAVIA Coaches, lower coach productivity and soft sales volume.
Medifast (NYSE: MED ) stock is falling on Tuesday after the weight loss company released its earnings report for the first quarter of 2024. The bad news for MED stock comes from its adjusted earnings per share of 66 cents.
Medifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing difficulties in attracting customers due to the rapidly changing economy and inflation.
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. T.
Medifast (MED) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Medifast (MED) is foraying into medically supported weight management and sports nutrition segments. However, it continues to encounter difficulties in attracting customers.
One tool that bargain hunters can utilize to identify beaten up stocks to buy after significant declines is the relative strength index ( RSI ). The RSI signals when a stock's downward momentum may be exhausted, indicating that a correction could provide upside potential.
Medifast's (MED) Q4 results reflect the impacts of poor customer acquisition. However, it is showing resilience, banking on its strategic focus on medically supported weight loss, indicating potential for growth.
Medifast, Inc. (MED) Q4 2023 Earnings Call Transcript
Medifast (MED) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $3.70 per share a year ago.